Johnson & Johnson (JNJ) September 2026 Conference Transcript

further because there's a lot of you know other areas that you could be in yeah and you know them as well as we do Larry will certainly keep our eyes open but I think what really stands out not I think I know what really stands out relative to other players in the cardiovascular space is that we are only participating in truly high-growth areas both in electrophysiology heart failure and IVL with truly differentiated innovation and so that always will be in our view a recipe for success we're not looking at any of those commodity businesses we are looking for truly differentiate innovation which makes a big difference for patients and delivers the returns that that we owe you as shareholders all right that's great so we've got about a minute left Tim if you want to make any closing remarks or any touch on any areas we didn't please you know feel free yeah I'll just close out with you know a couple comments firstly you know we're confident with the progress we've made this is a time of significant transformation for Johnson & Johnson, especially on our portfolio as we shift our business into higher growth markets like cardiovascular, as we move out slower growing market businesses like orthopedics. And so very confident in the ongoing transformation of the portfolio. And that's a good reason for why we feel so confident in what we're going to share at the EBR later in the year and what we expect to be the contribution that MedTech makes to Johnson & Johnson more broadly over the next five to seven years. We're happy with the ongoing changes in our operating model. And while I haven't talked a lot about that, that is foundational to winning in MedTech, being highly specialized, highly focused, able to move with speed and intensity with the market. And finally, we just feel really confident in the future. And I'll end with the point I made earlier. we are very confident in Johnson & Johnson's ability to deliver on our 2026 commitments and the guidance we raised in July, and we believe that 27 will be stronger than 26.

Perfect. Thanks so much for being here.